Topical steroid containing combinations: Burden of adverse effects and why the recent regulatory action may not be enough

OBJECTIVES AND METHODS: In September 2018, the government of India banned 328 fixed dose combinations (FDCs), 24 of which are combinations containing topical steroids. To assess what impact can be expected from this regulatory action, we analyzed reports of adverse drug events due to topical cortico...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhaj, Ratinder, Asati, Dinesh Prasad, Chaudhary, Deepa, Sadasivam, Balakrishnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641741/
https://www.ncbi.nlm.nih.gov/pubmed/34854405
http://dx.doi.org/10.4103/ijp.IJP_728_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641741/
https://www.ncbi.nlm.nih.gov/pubmed/34854405
http://dx.doi.org/10.4103/ijp.IJP_728_19

Ejemplares similares